InvestorsHub Logo
icon url

honestabe13

05/17/12 10:02 AM

#80135 RE: jonnyrocket #80134

abstracts for pphm are absolutely, totally, and completely meaningless this year.

the pipeline has plenty of discoveries that will either be monetized eventually or just be neat science...like bavi and cotara are so far.

the share price only moves up now with excellent later-stage results or FDA blessings that set up near term licensing...

long-time holders like most of us are screwed otherwise.
icon url

cheynew

05/17/12 10:30 AM

#80136 RE: jonnyrocket #80134

On the ASCO site it marks us as a Featured Exhibitor. We have a slot next to Seattle Genetics.

http://events.jspargo.com/asco12/public/floorplan.aspx?MapID=192&BoothID=231414&Booth=24115

75 Word Paragraph
Peregrine Pharmaceuticals is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and infectious diseases. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers.


Cancer Types

Central Nervous System Tumors
Lung Cancer


Categories:

Antibodies
icon url

cheynew

05/17/12 10:31 AM

#80137 RE: jonnyrocket #80134

Since we are clearly going lower, maybe we can hope for a big bounce back with high volume off the lows.